Oxford Immunotec partners with UK COVID-19 human challenge study
Diagnostic company will provide its T-SPOT Discovery SARS-CoV-2 testing kit to detect T cells in study participants
Read More
Tag: UK human challenge study
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
